Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
LALCA 2019
2019 Latin America Lung Conference on Lung Cancer
(Mexico City, Mexico): October 17-19,2019
Presentation Date(s):- October 17-19,2019
- Total Presentations: 138
-
+
Session 1: Diagnostic Imaging Innovation
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 08:30 - 09:30, Castillo A 1-4
-
+
F1.01 - Diagnosis in LATAM Region: Differences in Access to Technology (Slides Available)
08:30 - 08:45 | Author(s): Marisol Arroyo Hern
- Abstract
Loading... -
+
F1.02 - EBUS and Navigation System to Yield a Diagnosis (Slides Available)
08:45 - 09:00 | Author(s): Francisco Tarrazzi
- Abstract
No abstract available for this presentation
-
+
F1.03 - Interventional Radiology and RFA (Slides Available)
09:00 - 09:15 | Author(s): Jorge Guerrero Ixtlahuac
- Abstract
Loading...
-
+
Session 2: Young Investigators Session & Research Envision
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 08:30 - 09:30, Castillo A 5-6
-
+
F2.01 - How to Write a Manuscript and a Research Grant (Slides Available)
08:30 - 08:45 | Author(s): Carlos Gil Ferreira
- Abstract
No abstract available for this presentation
-
+
F2.02 - The Role of Medical School to Promote Basic and Clinical Research in LATAM (Slides Available)
08:45 - 09:00 | Author(s): Norma Pilnik
- Abstract
No abstract available for this presentation
-
+
F2.03 - Be an Author from LATAM: Challenges and Opportunities (Slides Available)
09:00 - 09:15 | Author(s): Andres Felipe Cardona Zorrilla
- Abstract
No abstract available for this presentation
-
+
Session 3: 2019 American Society of Clinical Oncology (ASCO) / IASLC Symposia: Lung Cancer Pathology in the Era of Targeted Therapy
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 10:30 - 11:30, Castillo A 1-4
-
+
F3.01 - Tissue Quality Control for Molecular Testing and Challenges in LATAM
10:30 - 10:45 | Author(s): Alejandro Aviles
- Abstract
No abstract available for this presentation
-
+
F3.02 - New Massive Parallel Sequencing Platforms (NGS) Versus Tailored Panels (ddPCR) (Slides Available)
10:45 - 11:00 | Author(s): Ignacio Wistuba
- Abstract
Loading... -
+
F3.03 - Molecular Markers Available in LATAM (Slides Available)
11:00 - 11:15 | Author(s): Marileila Varella-Garcia
- Abstract
Loading...
-
+
Session 4: Novel Diagnostic and Prognostic Markers
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 10:30 - 11:30, Castillo A 5-6
-
+
F4.01 - Tumor Mutation Burden and Immunotherapy (Slides Available)
10:30 - 10:45 | Author(s): David R. Gandara
- Abstract
No abstract available for this presentation
-
+
F4.02 - New Technologies for Liquid Biopsies and Looking for Cost Effective Options for LATAM (RT-PCR, cfRNA, Exosomes, ECVs and CTCs) (Slides Available)
10:45 - 11:00 | Author(s): Luis E. Raez
- Abstract
Loading... -
+
F4.03 - Access to Biomarkers Analysis in Tissue and Blood for Our Patients in LATAM (Slides Available)
11:00 - 11:15 | Author(s): Clarissa Baldotto
- Abstract
No abstract available for this presentation
-
+
Session 5: Case Presentations and Review of New Developments in Surgery
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 11:45 - 12:45, Castillo A 1-4
-
+
F5.01 - Multidisciplinary Management and Surgery for llla Disease (Slides Available)
11:45 - 12:00 | Author(s): Ricardo Terra
- Abstract
No abstract available for this presentation
-
+
F5.02 - Management of Ground-Glass Opacities (GGO) (Slides Available)
12:00 - 12:15 | Author(s): Ricardo Santos
- Abstract
No abstract available for this presentation
-
+
F5.03 - Sublobar Resection for Stage I NSCLC (Slides Available)
12:15 - 12:30 | Author(s): Mark Block
- Abstract
Loading...
-
+
Session 6: Adjuvant Therapy in the Molecular Era
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 11:45 - 12:45, Castillo A 5-6
-
+
F6.01 - Role of Targeted Agents in the Adjuvant Setting (Slides Available)
11:45 - 12:00 | Author(s): Luis Alberto Mas Lopez
- Abstract
No abstract available for this presentation
-
+
F6.02 - Immunotherapy in Lung Cancer Adjuvant Setting? (Slides Available)
12:00 - 12:15 | Author(s): Edgardo S. Santos
- Abstract
No abstract available for this presentation
-
+
F6.03 - Which Adjuvant Therapy Can I Do in LATAM? (Slides Available)
12:15 - 12:30 | Author(s): Luis Corrales-Rodriguez
- Abstract
No abstract available for this presentation
-
+
Session 7: Radiotherapy Innovations
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 14:15 - 15:15, Castillo A 1-4
-
+
F7.01 - SBRT for Oligometastatic Disease (Slides Available)
14:15 - 14:30 | Author(s): Beatriz Amendola
- Abstract
Loading... -
+
F7.02 - Role of SBRT in Early Stage NSCLC in LATAM (Slides Available)
15:30 - 15:45 | Author(s): Ana Botero
- Abstract
No abstract available for this presentation
-
+
F7.03 - Optimal Radiotherapy for LA-NSCLC (Slides Available)
14:45 - 15:00 | Author(s): Puneeth Iyengar
- Abstract
Loading...
-
+
Session 8: Case Presentations and Review of Combined Modality Therapy
- Type: Invited Speaker Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 10/18/2019, 14:15 - 15:15, Castillo A 5-6
-
+
F8.01 - Combining Radiation Therapy with Targeted Therapy in Oligometastatic Disease (Slides Available)
14:15 - 14:30 | Author(s): Alberto Chiappori
- Abstract
No abstract available for this presentation
-
+
F8.02 - Immunotherapy for Locally Advanced Disease (Slides Available)
14:30 - 14:45 | Author(s): Edgardo S. Santos
- Abstract
No abstract available for this presentation
-
+
F8.03 - Is There a Role of Neoadjuvant Therapy in NSCLC? (Slides Available)
14:45 - 15:00 | Author(s): Ticiana Leal
- Abstract
No abstract available for this presentation
-
+
Session 10: Poster Discussion # 2: Metastatic Disease
- Type: Poster Discussion Session
- Track:
- Presentations: 8
- Slides Available
- Coordinates: 10/18/2019, 16:15 - 17:15, Castillo A 5-6
-
+
F10.01 - PD-L1 and Other Potential Predictive Biomarkers Measured in Plasma by RT-PCR in cfRNA and cfDNA to Monitor Clinical Responses in Metastatic Lung Cancer Patients (Slides Available)
16:15 - 16:20 | Author(s): Luis E. Raez
- Abstract
Loading... -
+
F10.02 - Pembrolizumab plus Pemetrexed-Platinum for Patients with Metastatic Nonsquamous NSCLC and Liver or Brain Metastases: Results from KEYNOTE-189 (Slides Available)
16:20 - 16:25 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
F10.03 - Exploration of Factors Relating to Immune Response in Patients Treated with Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (NSCLC) (Slides Available)
16:25 - 16:30 | Author(s): Claudio Martin
- Abstract
Loading... -
+
F10.03-1 - LALCA 2019 Poster Discussion (Slides Available)
16:30 - 16:40 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
F10.04 - Long Term Efficacy and Safety of Ensartinib in Pre-treated Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients (eXalt2) (Slides Available)
16:40 - 16:45 | Author(s): Ticiana Leal
- Abstract
Loading... -
+
F10.05 - Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study (Slides Available)
16:45 - 16:50 | Author(s): Maximillian Hochmair
- Abstract
Loading... -
+
F10.06 - EGFR Inhibitors + Bevacizumab Demonstrated Superior Efficacy Compared with EGFR Inhibitors Alone as First-line Treatment in Advanced NSCLC Patients with EGFR Mutations and BIM Deletion Polymorphisms (Slides Available)
16:50 - 16:55 | Author(s): Andres Felipe Cardona Zorrilla
- Abstract
Loading... -
+
F10.07 - Poster Discussion: PD2.04, PD2.05, PD2.06 Updates with EGFR/ALK TKIs (Slides Available)
16:55 - 17:05 | Presenter: Heather A Wakelee
- Abstract
No abstract available for this presentation
-
+
Session 9: Poster Discussion # 1: Diagnosis, Early Stage and Locally Advanced
- Type: Poster Discussion Session
- Track:
- Presentations: 8
- Slides Available
- Coordinates: 10/18/2019, 16:15 - 17:15, Castillo A 1-4
-
+
F9.01 - Associations of Variability in Metabolic Parameters with Lung Cancer in the General Population (Slides Available)
16:15 - 16:20 | Author(s): In Young Cho
- Abstract
Loading... -
+
F9.02 - Non-Small Cell Lung Cancer in the US Hispanic Population: A National Cancer Database Analysis (Slides Available)
16:20 - 16:25 | Author(s): Goetz Kloecker
- Abstract
Loading... -
+
F9.03 - A Primer on Genetic Counseling on the Thoracic Oncology Unit. Family History of Lung Cancer in Two Independent Populations Tested for BRCA1 & amp;2 and EGFR (Slides Available)
16:25 - 16:30 | Author(s): Guillermo Pacheco Cuellar
- Abstract
Loading... -
+
F9.03-1 - Poster Discussion (Slides Available)
16:30 - 16:40 | Presenter: Paul Bunn, Jr.
- Abstract
No abstract available for this presentation
-
+
F9.04 - Mid-term Outcomes of Uniportal Vats(U-VATS) for Early Lung Cancer (Slides Available)
16:40 - 16:45 | Author(s): Kyoji Hirai
- Abstract
Loading... -
+
F9.05 - Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced Non-small-cell Lung Cancer (CLICAP-ABs) (Slides Available)
16:45 - 16:50 | Author(s): Feliciano Barr
- Abstract
Loading... -
+
F9.06 - Improving Survival of Oligometastatic NSCLC with Stereotactic Body Radiation Therapy (Slides Available)
16:50 - 16:55 | Author(s): Luis E. Raez
- Abstract
Loading... -
+
F9.07 - Poster Discussion (Slides Available)
16:55 - 17:05 | Presenter: Rafael Rosell
- Abstract
No abstract available for this presentation
first
prev
